Eagle Bay Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-326
| Closed | -$170K | – | 872 |
|
|
2024
Q4 | $170K | Sell |
326
-117
| -26% | -$60.9K | 0.11% | 130 |
|
|
2024
Q3 | $274K | Sell |
443
-11
| -2% | -$6.8K | 0.1% | 139 |
|
|
2024
Q2 | $251K | Sell |
454
-207
| -31% | -$114K | 0.15% | 100 |
|
|
2024
Q1 | $384K | Sell |
661
-83
| -11% | -$48.2K | 0.24% | 72 |
|
|
2023
Q4 | $395K | Sell |
744
-7
| -0.9% | -$3.72K | 0.25% | 71 |
|
|
2023
Q3 | $380K | Buy |
751
+295
| +65% | +$149K | 0.18% | 85 |
|
|
2023
Q2 | $238K | Sell |
456
-334
| -42% | -$174K | 0.14% | 104 |
|
|
2023
Q1 | $455K | Sell |
790
-215
| -21% | -$124K | 0.25% | 64 |
|
|
2022
Q4 | $553K | Buy |
1,005
+216
| +27% | +$119K | 0.31% | 57 |
|
|
2022
Q3 | $401K | Buy |
789
+9
| +1% | +$4.57K | 0.25% | 68 |
|
|
2022
Q2 | $424K | Buy |
780
+768
| +6,400% | +$417K | 0.26% | 61 |
|
|
2022
Q1 | $6K | Sell |
12
-433
| -97% | -$217K | ﹤0.01% | 260 |
|
|
2021
Q4 | $297K | Sell |
445
-69
| -13% | -$46.1K | 0.19% | 73 |
|
|
2021
Q3 | $293K | Buy |
514
+326
| +173% | +$186K | 0.16% | 86 |
|
|
2021
Q2 | $97K | Buy |
+188
| New | +$97K | 0.08% | 159 |
|